Effects of doxycycline on clinical, microbiological and immunological parameters in well-controlled diabetes type-2 patients with periodontal disease: a randomized, controlled clinical trial
(Journal of Clinical Periodontology; doi: 10.1111/jcpe.12287)
Lazaros Tsalikis, Dimitra Sakellari, Panagiotis Dagalis, Panagiota Boura, Antonios Konstantinidis
Antibiotics are sometimes added to gum cleaning, but the extra benefit needs to be demonstrated. This trial tested doxycycline in people with type 2 diabetes and periodontitis.
Sixty-six participants with relatively well-managed diabetes received professional cleaning below the gumline and either doxycycline or placebo. Researchers compared gum measurements, bacteria, an inflammation-related marker and HbA1c over six months.
Both groups’ gums improved. There was no consistent overall advantage from doxycycline in the main periodontal measures or bacterial findings. Some individual site and laboratory measurements favoured it, but HbA1c did not change clearly in either group. Small differences in a marker do not necessarily translate into a benefit patients notice.
The findings do not support automatically adding doxycycline to periodontal treatment simply because someone has diabetes. They also apply mainly to participants with relatively well-managed glucose and may not describe other groups. The important question is whether an additional medicine offers enough benefit for the particular dental problem to justify its disadvantages. This short trial does not establish a lasting glucose benefit or a universally preferable antibiotic schedule.
The selected study population does not represent every level of diabetes severity. The most useful comparison is the difference between the treatment groups, rather than improvement within just one group. Results also depend on who took part, the comparison care and how long people were followed. A statistically uncertain difference does not prove two approaches are identical. Equally, a clear difference in a measurement may not show a lasting benefit for tooth retention or general health. These findings need to be considered alongside other trials and your individual clinical needs when discussing treatment choices.
Read the full article Back to Research
Periodontitis is the 6th most prevalent condition globally
Periodontitis and diabetes are bidirectionally linked
Diabetic complications are increased if you have both diseases
Successful periodontal treatment can improve blood glucose control
Periodontitis is the 6th most prevalent condition globally
Periodontitis and diabetes are bidirectionally linked
Diabetic complications are increased if you have both diseases
Successful periodontal treatment can improve blood glucose control
